SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001753926-20-000082
Filing Date
2020-04-08
Accepted
2020-04-07 18:43:59
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A g081950_13ga.htm SC 13G/A 51363
  Complete submission text file 0001753926-20-000082.txt   52873
Mailing Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540
Business Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540 609-375-2227
Sonnet BioTherapeutics Holdings, Inc. (Subject) CIK: 0001106838 (see all company filings)

IRS No.: 522102141 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-81795 | Film No.: 20780729
SIC: 2834 Pharmaceutical Preparations

Mailing Address THE EZRALOW CO, LLC 23622 CALABASAS ROAD, SUITE 200 CALABASAS CA 91302-1549
Business Address
Ezralow Bryan (Filed by) CIK: 0001697957 (see all company filings)

Type: SC 13G/A